Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats

It has been demonstrated previously that exogenous ketone supplements such as ketone ester (KE) decreased absence epileptic activity in a well-studied animal model of human absence epilepsy, Wistar Albino Glaxo/Rijswijk (WAG/Rij) rats. It is known that lipopolysaccharide (LPS)-generated changes in i...

Full description

Bibliographic Details
Main Authors: Zsolt Kovács, Dominic P. D'Agostino, David M. Diamond, Csilla Ari
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2019.00045/full
_version_ 1819047235111878656
author Zsolt Kovács
Dominic P. D'Agostino
Dominic P. D'Agostino
David M. Diamond
David M. Diamond
Csilla Ari
author_facet Zsolt Kovács
Dominic P. D'Agostino
Dominic P. D'Agostino
David M. Diamond
David M. Diamond
Csilla Ari
author_sort Zsolt Kovács
collection DOAJ
description It has been demonstrated previously that exogenous ketone supplements such as ketone ester (KE) decreased absence epileptic activity in a well-studied animal model of human absence epilepsy, Wistar Albino Glaxo/Rijswijk (WAG/Rij) rats. It is known that lipopolysaccharide (LPS)-generated changes in inflammatory processes increase absence epileptic activity, while previous studies show that ketone supplement-evoked ketosis can modulate inflammatory processes. Thus, we investigated in the present study whether administration of exogenous ketone supplements, which were mixed with standard rodent chow (containing 10% KE + 10% ketone salt/KS, % by weight, KEKS) for 10 days, can modulate the LPS-evoked changes in absence epileptic activity in WAG/Rij rats. At first, KEKS food alone was administered and changes in spike-wave discharge (SWD) number, SWD time, discharge frequency within SWDs, blood glucose, and beta-hydroxybutyrate (βHB) levels, as well as body weight and sleep-waking stages were measured. In a separate experiment, intraperitoneal (i.p.) injection of LPS (50 μg/kg) alone and a cyclooxygenase 1 and 2 (COX-1 and COX-2) inhibitor indomethacin (10 mg/kg) alone, as well as combined IP injection of indomethacin with LPS (indomethacin + LPS) were applied in WAG/Rij rats to elucidate their influences on SWD number. In order to determine whether KEKS food can modify the LPS-evoked changes in SWD number, KEKS food in combination with IP LPS (50 μg/kg) (KEKS + LPS), as well as KEKS food with IP indomethacin (10 mg/kg) and LPS (50 μg/kg) (KEKS + indomethacin + LPS) were also administered. We demonstrated that KEKS food significantly increased blood βHB levels and decreased not only the spontaneously generated absence epileptic activity (SWD number), but also the LPS-evoked increase in SWD number in WAG/Rij rats. Our results suggest that administration of exogenous ketone supplements (ketogenic foods) may be a promising therapeutic tool in the treatment of epilepsy.
first_indexed 2024-12-21T10:57:08Z
format Article
id doaj.art-0c35bcdd8abe4d2c902da4925b3ebcc8
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-12-21T10:57:08Z
publishDate 2019-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-0c35bcdd8abe4d2c902da4925b3ebcc82022-12-21T19:06:28ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992019-02-011210.3389/fnmol.2019.00045438813Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk RatsZsolt Kovács0Dominic P. D'Agostino1Dominic P. D'Agostino2David M. Diamond3David M. Diamond4Csilla Ari5Department of Biology, ELTE Eötvös Loránd University, Savaria University Centre, Szombathely, HungaryLaboratory of Metabolic Medicine, Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United StatesInstitute for Human and Machine Cognition, Ocala, FL, United StatesLaboratory of Metabolic Medicine, Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United StatesComparative Neuroscience Research Laboratory, Department of Psychology, University of South Florida, Tampa, FL, United StatesComparative Neuroscience Research Laboratory, Department of Psychology, University of South Florida, Tampa, FL, United StatesIt has been demonstrated previously that exogenous ketone supplements such as ketone ester (KE) decreased absence epileptic activity in a well-studied animal model of human absence epilepsy, Wistar Albino Glaxo/Rijswijk (WAG/Rij) rats. It is known that lipopolysaccharide (LPS)-generated changes in inflammatory processes increase absence epileptic activity, while previous studies show that ketone supplement-evoked ketosis can modulate inflammatory processes. Thus, we investigated in the present study whether administration of exogenous ketone supplements, which were mixed with standard rodent chow (containing 10% KE + 10% ketone salt/KS, % by weight, KEKS) for 10 days, can modulate the LPS-evoked changes in absence epileptic activity in WAG/Rij rats. At first, KEKS food alone was administered and changes in spike-wave discharge (SWD) number, SWD time, discharge frequency within SWDs, blood glucose, and beta-hydroxybutyrate (βHB) levels, as well as body weight and sleep-waking stages were measured. In a separate experiment, intraperitoneal (i.p.) injection of LPS (50 μg/kg) alone and a cyclooxygenase 1 and 2 (COX-1 and COX-2) inhibitor indomethacin (10 mg/kg) alone, as well as combined IP injection of indomethacin with LPS (indomethacin + LPS) were applied in WAG/Rij rats to elucidate their influences on SWD number. In order to determine whether KEKS food can modify the LPS-evoked changes in SWD number, KEKS food in combination with IP LPS (50 μg/kg) (KEKS + LPS), as well as KEKS food with IP indomethacin (10 mg/kg) and LPS (50 μg/kg) (KEKS + indomethacin + LPS) were also administered. We demonstrated that KEKS food significantly increased blood βHB levels and decreased not only the spontaneously generated absence epileptic activity (SWD number), but also the LPS-evoked increase in SWD number in WAG/Rij rats. Our results suggest that administration of exogenous ketone supplements (ketogenic foods) may be a promising therapeutic tool in the treatment of epilepsy.https://www.frontiersin.org/article/10.3389/fnmol.2019.00045/fullketone supplementsketosisLPSinflammationabsence epilepsyWAG/Rij rats
spellingShingle Zsolt Kovács
Dominic P. D'Agostino
Dominic P. D'Agostino
David M. Diamond
David M. Diamond
Csilla Ari
Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats
Frontiers in Molecular Neuroscience
ketone supplements
ketosis
LPS
inflammation
absence epilepsy
WAG/Rij rats
title Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats
title_full Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats
title_fullStr Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats
title_full_unstemmed Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats
title_short Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats
title_sort exogenous ketone supplementation decreased the lipopolysaccharide induced increase in absence epileptic activity in wistar albino glaxo rijswijk rats
topic ketone supplements
ketosis
LPS
inflammation
absence epilepsy
WAG/Rij rats
url https://www.frontiersin.org/article/10.3389/fnmol.2019.00045/full
work_keys_str_mv AT zsoltkovacs exogenousketonesupplementationdecreasedthelipopolysaccharideinducedincreaseinabsenceepilepticactivityinwistaralbinoglaxorijswijkrats
AT dominicpdagostino exogenousketonesupplementationdecreasedthelipopolysaccharideinducedincreaseinabsenceepilepticactivityinwistaralbinoglaxorijswijkrats
AT dominicpdagostino exogenousketonesupplementationdecreasedthelipopolysaccharideinducedincreaseinabsenceepilepticactivityinwistaralbinoglaxorijswijkrats
AT davidmdiamond exogenousketonesupplementationdecreasedthelipopolysaccharideinducedincreaseinabsenceepilepticactivityinwistaralbinoglaxorijswijkrats
AT davidmdiamond exogenousketonesupplementationdecreasedthelipopolysaccharideinducedincreaseinabsenceepilepticactivityinwistaralbinoglaxorijswijkrats
AT csillaari exogenousketonesupplementationdecreasedthelipopolysaccharideinducedincreaseinabsenceepilepticactivityinwistaralbinoglaxorijswijkrats